News details

Jul 16, 2024

Lallemand Pharma has announced a groundbreaking partnership with Avalon Pharma, a dynamic Saudi pharmaceutical firm. Together, they aim to boost respiratory health across the Kingdom of Saudi Arabia.

Key Highlights:

1. Collaboration for Better Breathing:
   • Lallemand Pharma and Avalon Pharma have joined forces to address respiratory health challenges in Saudi Arabia. By combining their expertise, resources, and innovative solutions, they seek to improve the quality of life for patients with respiratory conditions.
2. Introducing Salinose® Bagonvalve:
   • As part of this strategic collaboration, the companies are proud to introduce the Salinose® Bagonvalve. This technology offers precise and effective nasal irrigation, promoting respiratory well-being. The inclusion of the Symbiofilm ingredient, known for its clinical efficacy, further enhances its impact by inhibiting biofilm formation and viral adhesion.
3. Team Effort and Milestone Achievement:
   • Both teams, across various departments, have worked tirelessly to achieve this significant milestone. Their dedication and proactive approach have paved the way for improved healthcare outcomes in Saudi Arabia.
4. Looking Ahead:
   • Stay tuned for further updates as Lallemand Pharma and Avalon Pharma continue to innovate and collaborate. This partnership represents a shared commitment to advancing healthcare and making a positive impact on patients’ lives.